Increased copper-mediated oxidation of membrane phosphatidylethanolamine in autism

American Journal of Biochemistry and Biotechnology

Volumn 4, Issue 2, 2008, Pages 95-100

  Chauhan, Abha ^a   Sheikh, Ashfaq M ^a   Chauhan, Ved ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Autism; Copper; Lymphoblast; Membrane; Metals; Oxidation; Phospholipids

Indexed keywords

COPPER; DISEASES; METALS; OXIDATION; PHOSPHOLIPIDS;

AUTISM; LYMPHOBLASTS;

BIOLOGICAL MEMBRANES;

CADMIUM; CALCIUM ION; CERULOPLASMIN; COPPER; IRON; LIPID; LIPOSOME; METAL ION; PHOSPHATIDYLETHANOLAMINE; PLASMALOGEN; ZINC ION;

ARTICLE; AUTISM; BLOOD CHEMISTRY; CONTROLLED STUDY; COPPER METABOLISM; ERYTHROCYTE MEMBRANE; HUMAN; HUMAN CELL; LIPID BRAIN LEVEL; LYMPHOBLAST; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PROTEIN METABOLISM;

MUS;

EID: 42449157498     PISSN: 15533468     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajbbsp.2008.95.100     Document Type: Article

References (33)

1. Chauhan, A. and V. Chauhan, 2006. Oxidative stress in autism. Pathophysiology, 13: 171-181.
2. McGinnis, W.R., 2004. Oxidative stress in autism. Altern. Ther. Health Med., 10: 22-36.
3. Zoroglu, S.S., F. Armutcu, S. Ozen, A. Gurel, E. Sivasli, O. Yetkin and I. Meram, 2004. Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur. Arch. Psychiatry Clin. Neurosci., 254: 143-147.
4. Sogut, S., S.S. Zoroglu, H. Ozyurt, H.R. Yilmaz, F. Ozugurlu, E. Sivasli, O. Yetkin, M. Yanik, H. Tutkun, H.A. Savas, M. Tarakcioglu and O. Akyol, 2003. Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism. Clin. Chim. Acta, 331: 111-117.
5. Chauhan, A., V. Chauhan, W.T. Brown and I.L. Cohen, 2004. Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin - the antioxidant proteins. Life Sci., 75: 2539-2549.
6. Chauhan, V., A. Chauhan, I.L. Cohen, W.T. Brown and A. Sheikh, 2004. Alteration in amino-glycerophospholipids levels in the plasma of children with autism: a potential biochemical diagnostic marker. Life Sci., 74: 1635-1643.
7. Ming, X., T.P. Stein, M. Brimacombe, W.G. Johnson, G.H. Lambert and G.C. Wagner, 2005. Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot. Essent. Fatty Acids, 73: 379-384.
8. James, S.J., P. Cutler, S. Melnyk, S. Jernigan, L. Janak, D.W. Gaylor and J.A. Neubrander, 2004. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr., 80: 1611-1617.
9. Vassiliev, V., Z.L. Harris and P. Zatta, 2005. Ceruloplasmin in neurodegenerative diseases. Brain Res. Brain Res. Rev., 49: 633-640.
10. Arnaud, P., E. Gianazza and L. Miribel, 1988. Ceruloplasmin. Methods Enzymol., 163: 441-452.
11. Gutteridge, J.M, 1983. Antioxidant properties of ceruloplasmin towards iron- and copper-dependent oxygen radical formation. FEBS Lett., 157: 37-40.
12. Horn, N., T. Tonnesen and Z. Tumer, 1992. Menkes disease: an X-linked neurological disorder of the copper metabolism. Brain Pathol., 2: 351-362.
13. Wendland, B.E., C.E. Greenwood, I. Weinberg and K.W.Young, 2003. Malnutrition in institutionalized seniors: the iatrogenic component. J. Am. Geriatr. Soc., 51: 85-90.
14. Kumar, N., 2006. Copper deficiency myelopathy (human swayback). Mayo Clin. Proc., 81: 1371-1384.
15. Kassu, A., T. Yabutani, Z.H. Mahmud, A. Mohammad, N. Nguyen, B.T. Huong, G. Hailemariam, E. Diro, B. Ayele, Y. Wondmikun, J. Motonaka and F. Ota, 2006. Alterations in serum levels of trace elements in tuberculosis and HIV infections. Eur. J. Clin. Nutr., 60: 580-586.
16. Ko, W.S., C.H. Guo, M.S. Yeh, L.Y. Lin, G.S. Hsu, P.C. Chen, M.C. Luo and C.Y. Lin, 2005. Blood micronutrient, oxidative stress and viral load in patients with chronic hepatitis C. World J. Gastroenterol., 11: 4697-4702.
17. Molteni, A., W.F. Ward, Y.T. Kim, R. Shetty, L. Brizio-Molteni, R. Giura, H. Ribner and M. Lomont, 1989. Serum copper concentration as an index of clinical lung injury. Adv. Exp. Med. Biol., 258: 273-285.
18. Das, S.K. and K. Ray, 2006. Wilson's disease: an update. Nat. Clin. Pract. Neurol., 2: 482-493.
19. Wapnir, R.A., 1998. Copper absorption and bioavailability. Am. J. Clin. Nutr., 67: 1054S-1060S.
20. Yilmaz, A., R.A. Sari, M. Gundogdu, N. Kose and E. Dag, 2005. Trace elements and some extracellular antioxidant proteins levels in serum of patients with systemic lupus erythematosus. Clin. Rheumatol., 24: 331-335.
21. Chauhan, V., A. Sheikh, A. Chauhan, J. Tsiouris, M. Malik and M. Vaughan, 2002. Changes during hibernation in different phospholipid and free and esterified cholesterol serum levels in black bears. Biochimie, 84: 1031-1034.
22. Poling, J.S., R.E. Frye, J. Shoffner and A.W. Zimmerman, 2006. Developmental regression and mitochondrial dysfunction in a child with autism. J. Child Neurol., 21: 170-172.
23. Rossignol, D.A. and L.W. Rossignol, 2006. Hyperbaric oxygen therapy may improve symptoms in autistic children. Med. Hypotheses, 67: 216-228.
24. Yorbik, O., A. Sayal, C. Akay, D.I. Akbiyik and T. Sohmen, 2002. Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins Leukot. Essent. Fatty Acids, 67: 341-343.
25. Lombard, J., 1998. Autism: a mitochondrial disorder? Med. Hypotheses, 50: 497-500.
26. Reiss, D., K. Beyer and B. Engelmann, 1997. Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro. Biochem. J., 323: 807-814.
27. Maeba, R. and N. Ueta, N., 2004. A novel antioxidant action of ethanolamine plasmalogens in lowering the oxidizability of membranes. Biochem. Soc. Trans., 32: 141-143.
28. Visioli, F., R. Bordone, C. Perugini, M. Bagnati, C. Cau and G. Bellomo, 2000. The kinetics of copper-induced LDL oxidation depend upon its lipid composition and antioxidant content. Biochem. Biophys. Res. Commun., 268: 818-822.
29. Nakano, E., M.P. Williamson, N.H. Williams and H.J. Powers, 2004. Copper-mediated LDL oxidation by homocysteine and related compounds depends largely on copper ligation. Biochim. Biophys. Acta, 1688: 33-42.
30. Hahnel, D., J. Thiery, T. Brosche and B. Engelmann, 1999. Role of plasmalogens in the enhanced resistance of LDL to copper-induced oxidation after LDL apheresis. Arterioscler. Thromb. Vasc. Biol., 19: 2431-2438.
31. Kontush, A., S. Meyer, B. Finckh, A. Kohlschutter and U. Beisiegel, 1996. Alpha-tocopherol as a reductant for Cu(II) in human lipoproteins. Triggering role in the initiation of lipoprotein oxidation. J. Biol. Chem., 271: 11106-11112.
32. Bittner, O., S. Gal, I. Pinchuk, D. Danino, H. Shinar and D. Lichtenberg, 2002. Copper-induced peroxidation of liposomal palmitoyl linoleoyl phosphatidylcholine (PLPC), effect of antioxidants and its dependence on the oxidative stress. Chem. Phys. Lipids, 114: 81-98.
33. Hahnel, D., T. Huber, V. Kurze, K. Beyer and B. Engelmann, 1999. Contribution of copper binding to the inhibition of lipid oxidation by plasmalogen phospholipids. Biochem. J., 340 (Pt 2): 377-383.